Fig. 2From: Therapeutic advances in anaplastic thyroid cancer: a current perspectiveDifferent promising drugs/inhibitors that target several hallmarks of ATC including uncontrolled proliferation, resistance to apoptosis, immunosuppression, Epigenetic reprogramming, angiogenesis and metabolomic alterationsBack to article page